PTEN过表达及突变对活化肝星状细胞黏着斑激酶信号转导的影响研究

doi:10.3969/j.issn.1007-9572.2016.29.011

摘要/Abstract

摘要： 目的　探讨过表达的野生型第10号染色体缺失的磷酸酶张力蛋白同源物基因（PTEN）及其突变体G129E（仅保留蛋白磷酸酶活性而丧失脂质磷酸酶活性）对活化肝星状细胞（HSC）黏着斑激酶（FAK）信号转导的影响。方法　2014年12月—2015年6月，利用瞬时转染技术，以腺病毒为载体将野生型PTEN及其突变体G129E转染到体外培养的活化HSC；实验分为4组：对照组：腺病毒转染时以DMEM基础培养基代替腺病毒；Ad-GFP组：转染表达绿色荧光蛋白（GFP）的载体空病毒Ad-GFP；Ad-PTEN组：转染携带野生型PTEN并表达GFP的重组腺病毒Ad-PTEN；Ad-G129E组：转染携带G129E并表达GFP的重组腺病毒Ad-G129E。应用Western blotting法检测活化HSC中PTEN、FAK、磷酸化FAK〔p-FAK（Tyr397）〕表达，实时荧光定量PCR法检测活化HSC中PTEN、FAK mRNA表达。结果　腺病毒转染活化HSC 48 h，4组活化HSC中PTEN及其mRNA表达比较，差异有统计学意义（P0.05）。4组活化HSC中FAK及其mRNA表达比较，差异无统计学意义（P>0.05）。4组活化HSC中p-FAK（Tyr397）表达比较，差异有统计学意义（P0.05）。结论　过表达的野生型PTEN及其突变体G129E均可通过抑制活化HSC的FAK磷酸化负性调控体外活化HSC的FAK信号转导。

关键词: 肝纤维化, 肝星状细胞, 第10号染色体缺失的磷酸酶张力蛋白同源物基因, 黏着斑激酶, 信号传导

Abstract: Objective　To investigate the overexpression of wild-type PTEN and its mutant G129E on focal adhesion kinase（FAK） signal transduction in activated hepatic stellate cells（HSC） in vitro.Methods　Using transient transfection technique，the wild-type PTEN gene and G129E gene were transduced into the cultured activated HSC mediated by adenoviral vector from December 2014 to June 2015.Cells were grouped as follows:control group，activated HSC were transfected with DMEM basal medium instead of adenovirus.Ad-GFP group，activated HSC were infected with adenovirus expressing green fluorescent protein（GFP）.Ad-PTEN group，activated HSC were infected with the recombinant adenovirus containing both wild type PTEN and GFP gene.Ad-G129E group，activated HSC were infected with adenovirus harboring both PTEN mutant G129E and GFP gene.The protein expression of PTEN,FAK and phosphorylated FAK〔p-FAK（Tyr397）〕 in activated HSC were detected by Western blotting.PTEN and FAK mRNA levels were detected by real-time fluorescent quantitation PCR.Results　At 48 hours after adenovirus transfection，there were statistically significant difference in the expressions of PTEN protein and mRNA in activated HSC among 4 groups（P<0.05）,the expressions of PTEN protein and mRNA in activated HSC in Ad-PTEN group and Ad-G129E group were higher than those in control group and Ad-GFP group（P<0.05）,there were no statistically significant difference in the expressions of PTEN protein and mRNA in activated HSC between control group and Ad-GFP group or Ad-PTEN group and Ad-G129E group（P>0.05）.There were no statistically significant difference in the expressions of FAK protein and mRNA in activated HSC among 4 groups（P>0.05）.There was statistically significant difference in the expression of p-FAK（Tyr397）in activated HSC among 4 groups（P<0.05）,the expression of p-FAK（Tyr397）in activated HSC in Ad-PTEN group and Ad-G129E group was lower than that in control group and Ad-GFP group（P<0.05）,but there were no statistically significant difference in the expression of p-FAK（Tyr397）in activated HSC between control group and Ad-GFP group or Ad-PTEN group and Ad-G129E group（P>0.05）.Conclusion　The overexpression of wild-type PTEN and its mutant G129E can negatively regulate FAK signaling transduction by inhibiting phosphorylation of FAK in activated HSC in vitro.

Key words: Liver fibrosis, Hepatic stellate cells, PTEN, FAK, Signal transduction

魏月, 郝礼森, 任昌镇, 章广玲, 陈静, 王静, 莫艳波, 张明婷. PTEN过表达及突变对活化肝星状细胞黏着斑激酶信号转导的影响研究[J]. 中国全科医学, 2016, 19(29): 3562-3566.

WEI Yue, HAO Li-sen, REN Chang-zhen, ZHANG Guang-ling, CHEN Jing, WANG Jing, MO Yan-bo, ZHANG Ming-ting. Effects of PTEN Overexpression and Mutation on FAK Signal Transduction in Activated Hepatic Stellate Cells[J]. Chinese General Practice, 2016, 19(29): 3562-3566.

参考文献

［1］LEE U E，FRIEDMAN S L.Mechanisms of hepatic fibrogenesis［J］.Best Pract Res Clin Gastroenterol，2011，25（2）:195-206. ［2］SHIM J H，KIM Y S，BAHK Y Y.Proteome profile changes that are differentially regulated by lipid and protein phosphatase activities of tumor suppressor PTEN in PTEN-expressing U-87 MG human glioblastoma cells［J］.Proteomics，2006，6（1）:81-93. ［3］CAI X M，TAO B B，WANG L Y，et al.Protein phosphatase activity of PTEN inhibited the invasion of glioma cells with epidermal growth factor receptor mutation type Ⅲ expression［J］.Int J Cancer,2005,117（6）:905-912. ［4］郝礼森，张晓岚，任昌镇，等.PTEN过表达抑制体外活化肝星状细胞 Akt的磷酸化［J］.实用医学杂志,2014,30（7）:1069-1072. HAO L S,ZHANG X L,REN C Z，et al.Overexpression of the tumor suppressor gene PTEN inhibits the phosphorylation of Akt in activated hepatic stellate cells in vitro［J］.The Journal of Practical Medicine，2014，30（7）:1069-1072. ［5］AROCHO A，CHEN B，LADANYI M，et al.Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts［J］.Diagn Mol Pathol，2006，15（1）:56-61. ［6］COX B D，NATARAJAN M，STETTNER M R，et al.New concepts regarding focal adhesion kinase promotion of cellm igrationand proliferation［J］.J Cell Biochem,2006,99（1）:35-52. ［7］MACAGNO J P，DIAZ VERA J，YU Y，et al.FAK acts as a suppressor of RTK-MAP kinase signaling in Drosophila melanogaster epithelia and human cancer cells［J］.PLoS Genet,2014,10（3）:e1004262. ［8］DERAMAUDT T B，DUJARDIN D，NOULET F，et al.Altering FAK-paxillin interactions reduces adhesion，migration and invasion processes［J］.PLoS One,2014,9（3）:e92059. ［9］CHENG Z K,DIMICHELE L A,ROJAS M,et al.Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21（Cip1.）［J］.J Mol Cell Cardiol,2014,67:1-11. ［10］LUO M，GUAN J L.Focal adhesion kinase:a prominent determinant in breast cancer initiation，progression and metastasis［J］.Cancer Lett,2010,289（2）:127-139. ［11］SULZMAIER F J，JEAN C，SCHLAEPFER D D.FAK in cancer:mechanistic findings and clinical applications［J］.Nat Rev Cancer,2014,14（9）:598-610. ［12］张晓岚,霍晓霞,申建刚,等.黏着斑激酶酪氨酸磷酸化促大鼠肝纤维化形成及其可能机制［J］.基础医学与临床，2007,27（2）:143-147. ZHANG X L,HUO X X,SHEN J G,et al.Focal adhesion kinase tyrosine phosphorylation promotes rat hepatic fibrogenesis and its possible mechanism［J］.Basic ＆ Clinical Medicine,2007,27（2）:143-147. ［13］安君艳，张晓岚，姚冬梅，等.体外RNA干扰下调黏着斑激酶表达对HSC-T6细胞黏附与迁移的影响［J］.中华肝脏病杂志，2009,17（7）:509-514. AN J Y，ZHANG X L，YAO D M，et al.The influence of down-regulation of focal adhesion kinase by RNA interference on the adhesion and migration of rat hepatic stellate cells in vitro［J］.Chinese Journal of Hepatology，2009,17（7）:509-514. ［14］RAFTOPOULOU M,ETIENNE-MANNEVILLE S,SELF A，et al.Regulation of cell migration by the C2 domain of tumor suppressor PTEN［J］.Science,2004,303（5661）:1179-1181. ［15］DASARI V R，KAUR K，VELPULA K K，et al.Upregulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway［J］.PLoS One,2010,5（4）:e10350. ［16］TIAN T，NAN K J，GUO H，et al.PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway［J］.Oncol Rep,2010,23（6）:1593-1600. ［17］HLOBILKOV A，KNILLOV J，BRTEK J，et al.The mechanism of action of the tumour suppressor gene PTEN［J］.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2003,147（1）:19-25. ［18］DAS S，DIXON J E，CHO W.Membrane-binding and activation mechanism of PTEN［J］.Proc Natl Acad Sci U S A，2003,100（13）:7491-7496. ［19］赵红霞.PTEN与肿瘤的相关性研究进展［J］.武汉大学学报（医学版）,2014,35（1）:155-159. ZHAO H X.Research progress in PTEN and tumor development［J］.Medical Journal of Wuhan University，2014,35（1）:155-159.

[1]	范学明, 杨宁宁, 郑症, 吴玉梅, 王祺. 2型糖尿病合并代谢相关脂肪性肝病患者微血管病变发生的相关因素分析及预测价值研究[J]. 中国全科医学, 2025, 28(36): 4578-4585.
[2]	吴莎, 张代义, 李晋, 宣勤考, 钱晓东, 朱传武, 浦剑虹, 朱莉. 基于体检队列的代谢相关脂肪性肝病与高血糖关联及联合预测模型构建研究[J]. 中国全科医学, 2025, 28(23): 2861-2869.
[3]	聂媛媛, 方达, 徐浩, 杨东辉, 毕艳, 顾天伟. 不同肝纤维化风险的2型糖尿病患者临床特征及心血管疾病风险研究[J]. 中国全科医学, 2025, 28(15): 1847-1854.
[4]	卓莉莉, 瞿欢佳, 张秋玲. 2型糖尿病与肥胖对纤维化4指数筛查非酒精性脂肪性肝病早期肝纤维化影响的研究[J]. 中国全科医学, 2025, 28(11): 1354-1360.
[5]	任凌萱, 卢子琪, 齐威, 冯志杰. 基于单细胞转录组学测序的巨噬细胞在肝硬化-肝癌疾病进展中的功能研究[J]. 中国全科医学, 2024, 27(29): 3654-3663.
[6]	彭逸伦, 李杨, 王晓桃. 多发性骨髓瘤细胞通过PI3K/AKT信号通路促进M2巨噬细胞极化的机制研究[J]. 中国全科医学, 2024, 27(08): 978-984.
[7]	贺佳, 李永平, 魏枫, 刘美岚, 吴亚玲, 韶龙格. 长链非编码RNA NEAT1、miRNA-182-5p与2型糖尿病合并代谢性脂肪性肝病患者肝纤维化风险的相关性研究[J]. 中国全科医学, 2024, 27(03): 300-307.
[8]	丛方远, 薛倩, 邓利华, 朱蕗颖, 王晶桐. 非酒精性脂肪性肝病与左心室早期舒张功能不全的相关性研究[J]. 中国全科医学, 2022, 25(26): 3290-3297.
[9]	张静怡，唐映梅. 慢性肝病与甲状腺功能障碍关系研究进展[J]. 中国全科医学, 2021, 24(33): 4281-4286.
[10]	王文玲，张馨元，叶松，李荣宽. 丙氨酸氨基转移酶水平对FibroTouch检测慢性乙型肝炎患者肝脏硬度值的影响研究[J]. 中国全科医学, 2021, 24(30): 3842-3847.
[11]	唐龙，邓永琼，王鸿，张志红，李晓明. 无创肝纤维化模型对慢性乙型病毒性肝炎肝纤维化的诊断价值研究[J]. 中国全科医学, 2020, 23(27): 3408-3415.
[12]	张燕*，范晓翔，章美武，庄鲁辉，毛达峰. LRC5调节转化生长因子-β1诱导的肝星状细胞活化及逆转对肝纤维化的影响[J]. 中国全科医学, 2020, 23(24): 3051-3059.
[13]	陈雪梅1*，江小英2，卢咏梅1，夏良华3. 声脉冲辐射力成像与实时剪切波弹性成像诊断肝纤维化程度的价值研究[J]. 中国全科医学, 2017, 20(30): 3796-3802.
[14]	刘怀鄂，游晶，洪敏，张艳梅，张禄，陆丽蓉，张茹薏，丁洁. 辅助性T淋巴细胞17/调节性T淋巴细胞平衡在乙型肝炎病毒感染相关肝纤维化进展过程中的作用研究[J]. 中国全科医学, 2016, 19(18): 2126-2129.
[15]	江罗佳，秦晓华，黄翀，房向东，涂卫平. 重组人促红细胞生成素治疗肾间质纤维化的作用机制研究[J]. 中国全科医学, 2016, 19(06): 672-677.